Premium reports How would the recent proposal to change the scheduling for CBD affect your business in Australia?
0

How would the recent proposal to change the scheduling for CBD affect your business in Australia?

Photo credit: Patty Jansen
Published: 15th October 2020 | No. pages: 18
$750.00

Description

CBD is listed on the Controlled Drug Register in Australia, which means that it can’t be sold as a consumer product. From June 2021, the Therapeutic Goods Administration has enabled access to such products through pharmacies, and without a prescription. This report provides a detailed overview of the current regulatory regime in place in Australia for these products, covering everything from the hemp plant itself to extracts and finished products.

New report guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new report for free.

Reasons to buy

A proposal has been put forward that would change the scheduling of CBD, which in turn has a number of consequences. If this, and the Australian market in general, interests you then this is the report for you. It not only provides information on the current regulatory regime for hemp and CBD in Australia, but it also offers analysis and data about the near future, as well as insight into the current status of medical and recreational cannabis.

Table of contents

  1. Executive summary
  2. Hemp plant
    1. The hemp plant definition
    2. Cultivation
    3. Strains
    4. THC
    5. Requirements to grow
    6. Disposal
    7. Processing
  3. Extracts as finished products
    1. CBD isolates
    2. Full/broad spectrum
    3. Flowers
  4. Finished products containing CBD and extracts
    1. Food
    2. Cosmetic products
    3. Vaping products
    4. Pet food
  5. Import/export
    1. Hemp
    2. CBD isolates and full spectrum
    3. Finished products
  6. Medical cannabis
    1. Access to cannabis-based medicinal products
    2. Production of medical cannabis (high THC plants/flowers)
    3. Near future
  7. Recreational cannabis
  8. Relevant laws
  9. Relevant bodies

Methodology

The research is completely original and conducted by CBD-Intel’s multilingual legal analysis team using several sources, including online and offline resources and data, specialised legal software, interviews with key stakeholders and government officials, and via the collaboration with local lawyers and on-the-ground profession.

Latest reports

Description

CBD is listed on the Controlled Drug Register in Australia, which means that it can’t be sold as a consumer product. From June 2021, the Therapeutic Goods Administration has enabled access to such products through pharmacies, and without a prescription. This report provides a detailed overview of the current regulatory regime in place in Australia for these products, covering everything from the hemp plant itself to extracts and finished products.

Get a free sample of this premium report:

“ How would the recent proposal to change the scheduling for CBD affect your business in Australia? ”





    -

    “ How would the recent proposal to change the scheduling for CBD affect your business in Australia? ”